Neutrophils: important contributors to tumor progression and metastasis
The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Abstract
The presence of neutrophils in tumors has traditionally been considered to be indicative of a failed immune response against cancers. However, there is now evidence showing that neutrophils can promote tumor growth, and increasingly, the data support an active role for neutrophils in tumor progression to distant metastasis. Neutrophils have been implicated in promoting metastasis in cancer patients, where neutrophil numbers and neutrophil-related factors and functions have been associated with progressive disease. Nevertheless, the role of neutrophils in tumors, both at the primary and secondary sites, remains controversial, with some studies reporting their anti-tumor functions. This review will focus on the data demonstrating a role for neutrophils in both tumor growth and metastasis and will attempt to clarify the discrepancies in the literature.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neutrophils represent a significant portion of cells in the TME (Swierczak et al., 2015; Powell and Huttenlocher, 2016), and their abundance has been linked to adverse prognostic outcomes in cancer patients (Hiramatsu et al., 2018; Schiffmann et al., 2019; Yin et al., 2019; Kim et al., 2022).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Swierczak et al., 2015
In the citing paper
“Neutrophils constitute a significant portion of the immune cells present within a TIME [4–8]”
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“Angiogenesis is essential for continued tumor growth [144].”
BackgroundInflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · cited 1×
“Given that tumors modify other infiltrating immune cells to promote tumor growth [105], it is not surprising that neutrophils may also be educated by the tumor microenvironment.”
BackgroundNew functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,908
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354 · cited 2×
“Arrest of neutrophils on the vascular endothelial surface via integrin binding to the immunoglobulin superfamily members such as intercellular adhesion molecule 1 (ICAM-1) and VCAM-1 [13]; 4.”
BackgroundTumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371 · cited 1×
“from untreated tumors expressed higher levels of arginase 1 [98], an enzyme typically associated with a trophic phenotype [99], while TANs isolated from mice treated with a type 1 TGFβ receptor kinase inhibitor displayed hyper-segmented nuclei, expressed higher levels of pro-inflammatory cytokines, and were more cytot…”
BackgroundTumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367 · cited 1×
“[3, 4], but now, emerging evidence also implicates neutrophils as active participants in cancer progression.”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288 · cited 3×
“Once at the pre-metastatic site, bone marrow-derived cells secrete factors that facilitate tumor cell survival and growth [10, 40] (Fig.”
BackgroundNOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125 · cited 1×
“NADPH activation initiates the neutrophil Brespiratory burst^ [15, 158], which is defined as the increased consumption of oxygen to create reactive oxygen species (ROS).”
BackgroundDevelopment of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049 · cited 1×
“Monocytes typically differentiate into macrophages and DCs in tissues [192], while granulocyt-”
BackgroundNeutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027 · cited 2×
“sponses via secretion of cytokines and chemokines [15, 16].”
BackgroundNeutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971 · cited 2×
“NADPH activation initiates the neutrophil Brespiratory burst^ [15, 158], which is defined as the increased consumption of oxygen to create reactive oxygen species (ROS).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
Role of angiogenesis in tumor growth and metastasis
Folkman, J. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37263 · Cited by 2,404
Role of angiogenesis in tumor growth and metastasis
FOLKMAN, J. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70065-1 · Cited by 2,400 · cited 1×
“required to provide sufficient nutrient and oxygen supplies, without which tumors fail to develop further [145].”
BackgroundClinical and Experimental Immunology
Kay, H. (1966) · PubMed Central · Cited by 2,177
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715 · cited 1×
“the primary lesion [190], such as TAM and TAN numbers, circulating monocyte and neutrophil numbers, or even systemic CSF-1 and G-CSF levels, to identify those who are most”
BackgroundIL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Coffelt, S. B., Kersten, K., Doornebal, C. W., Weiden, J., Vrijland, K., Hau, C.-S., Verstegen, N. J. M., Ciampricotti, M., Hawinkels, L. J. A. C., Jonkers, J., et al. (2015) · Nature · doi:10.1038/nature14282 · Cited by 1,703
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645 · cited 1×
“However, Gr-1 cells are not always considered to be MDSCs and are often described as neutrophils or macrophages [32, 33] or even monocytes [34].”
Background(1956) · Observations on the Alewife, Pomolobus Pseudoharengus (Wilson), in Fresh Wate · doi:10.3138/9781487596026-005 · Cited by 1,534
Granules of the Human Neutrophilic Polymorphonuclear Leukocyte
Borregaard, N., & Cowland, J. B. (1997) · Blood · doi:10.1182/blood.v89.10.3503 · Cited by 1,522
Ries, C. H., Cannarile, M. A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L. P., Feuerhake, F., Klaman, I., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.016 · Cited by 1,384 · cited 1×
“Although anti-CSF-1R antibody treatment significantly reduced TAMs, there was an associated increase in other immune cells, particularly Ly6G neutrophils [191].”
BackgroundAlmand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337 · cited 3×
“Gr-1CD11b cells have been implicated in the formation of the pre-metastatic niche [9], and their human counterparts are increased in cancer patients [29].”
BackgroundMMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276 · cited 1×
“chain of CD3 after TCR-signaling-induced internalization [25].”
Macrophage Polarization Comes of Age
Mantovani, Sica, & Locati, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.001 · Cited by 1,259 · cited 1×
“from untreated tumors expressed higher levels of arginase 1 [98], an enzyme typically associated with a trophic phenotype [99], while TANs isolated from mice treated with a type 1 TGFβ receptor kinase inhibitor displayed hyper-segmented nuclei, expressed higher levels of pro-inflammatory cytokines, and were more cytot…”
BackgroundMovahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., & Van Ginderachter, J. A. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,234
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
Colotta, F., Re, F., Polentarutti, N., Sozzani, S., & Mantovani, A. (1992) · Blood · doi:10.1182/blood.v80.8.2012.2012 · Cited by 1,158
(2011) · Hepatogastroenterology · doi:10.5754/hge11069 · Cited by 1,140
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140 · cited 1×
“They have even been shown to differentiate into endothelial cells in tumors [38].”
BackgroundThe inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Allavena, P., Sica, A., Solinas, G., Porta, C., & Mantovani, A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.07.004 · Cited by 1,044 · cited 1×
“[3, 4], but now, emerging evidence also implicates neutrophils as active participants in cancer progression.”
BackgroundNeutrophil serine proteases: specific regulators of inflammation
Pham, C. T. N. (2006) · Nature Reviews Immunology · doi:10.1038/nri1841 · Cited by 1,022
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 1,010
Journal of the Medical Association of Thailand
(2020) · Journal of the Medical Association of Thailand · doi:10.35755/jmedassocthai · Cited by 963
Nozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923 · cited 2×
“Reducing TAN numbers in murine models of tumor angiogenesis has shown promising results, and a similar strategy could be effective in human disease [138, 194].”
BackgroundYang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.004 · Cited by 918 · cited 1×
“Coinjection of 4T1 mammary tumor cells with Gr-1CD11b cells isolated from tumors and spleens of 4T1 tumor-bearing mice increased metastasis to lung, but not following coinjection of Gr-1CD11b cells from spleens of naïve mice [172].”
BackgroundBabior, B. M., Lambeth, J. D., & Nauseef, W. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2642 · Cited by 911 · cited 12×
“When the MO-MDSCs isolated from spleens of tumor-bearing mice were incubated with GM- CSF, they downregulated Ly6C expression, becoming Ly6G + cells with the morphology of neutrophils and with increased levels of ROS and MPO activity [31].”
BackgroundInfluentialRole of tumor-associated macrophages in tumor progression and invasion
Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9001-7 · Cited by 888
Chemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 839
The Terminology Issue for Myeloid-Derived Suppressor Cells
Gabrilovich, D. I., Bronte, V., Chen, S.-H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S., & Schreiber, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3037 · Cited by 835 · cited 3×
“While murine MDSCs are identified by their expression of Gr-1 and CD11b [17], human MDSCs are not as well characteri z e d b u t a r e t h o u g h t t o b e M H C c l a s s I I l o w CD33 + CD11b + CD14 neg CD15 + /lin neg [29].”
BackgroundJournal of the National Cancer Institute
(1969) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/43.6.1387 · Cited by 832
Neutrophils, host defense, and inflammation: a double-edged sword
Smith, J. A. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.6.672 · Cited by 811 · cited 1×
“grate to sites of inflammation or tissue damage, destroy invading pathogens and infected/damaged cells, and modulate inflammatory responses [12].”
BackgroundTumor entrained neutrophils inhibit seeding in the premetastatic lung
Granot, Z., Henke, E., Comen, E. A., King, T. A., Norton, L., & Benezra, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.012 · Cited by 782 · cited 2×
“[43] showing that depletion of neutrophils”
BackgroundLi, H., Han, Y., Guo, Q., Zhang, M., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.240 · Cited by 777
Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis
Weitzman, S., & Gordon, L. (1990) · Blood · doi:10.1182/blood.v76.4.655.655 · Cited by 764
Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth
Houghton, A. M., Rzymkiewicz, D. M., Ji, H., Gregory, A. D., Egea, E. E., Metz, H. E., Stolz, D. B., Land, S. R., Marconcini, L. A., Kliment, C. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2084 · Cited by 744 · cited 2×
“leading to proliferation of tumor cells and higher levels leading to tumor cell death [131].”
BackgroundReactive oxygen and nitrogen species as signaling molecules regulating neutrophil function
Fialkow, L., Wang, Y., & Downey, G. P. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.09.030 · Cited by 708 · cited 4×
“When the MO-MDSCs isolated from spleens of tumor-bearing mice were incubated with GM- CSF, they downregulated Ly6C expression, becoming Ly6G + cells with the morphology of neutrophils and with increased levels of ROS and MPO activity [31].”
BackgroundInfluentialTumor-associated neutrophils: friend or foe?
Fridlender, Z. G., & Albelda, S. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs123 · Cited by 699
Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis
Belaaouaj, A., McCarthy, R., Baumann, M., Gao, Z., Ley, T. J., Abraham, S. N., & Shapiro, S. D. (1998) · Nature Medicine · doi:10.1038/nm0598-615 · Cited by 691
Serafini, P., Mgebroff, S., Noonan, K., & Borrello, I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6621 · Cited by 673
Preparing the “Soil”: The Premetastatic Niche
Kaplan, R. N., Rafii, S., & Lyden, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2407 · Cited by 665
Kowanetz, M., Wu, X., Lee, J., Tan, M., Hagenbeek, T., Qu, X., Yu, L., Ross, J., Korsisaari, N., Cao, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015855107 · Cited by 663 · cited 7×
“phils can have a more profound effect on metastasis than depletion of TAMs [40, 189].”
BackgroundInfluentialHoechst, B., Voigtlaender, T., Ormandy, L., Gamrekelashvili, J., Zhao, F., Wedemeyer, H., Lehner, F., Manns, M. P., Greten, T. F., & Korangy, F. (2009) · Hepatology · doi:10.1002/hep.23054 · Cited by 643
Myeloid-derived suppressor cell heterogeneity and subset definition
Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., & Bronte, V. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.021 · Cited by 630 · cited 5×
“When the MO-MDSCs isolated from spleens of tumor-bearing mice were incubated with GM- CSF, they downregulated Ly6C expression, becoming Ly6G + cells with the morphology of neutrophils and with increased levels of ROS and MPO activity [31].”
BackgroundInfluentialFleming, T. J., Fleming, M. L., & Malek, T. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2399 · Cited by 619 · cited 1×
“In fact, Gr-1 does not distinguish between neutrophils and monocytes/macrophages but represents a composite of two different antigens, namely Ly6G, which is found on neutrophils, and Ly6C, which is found on monocytes and macrophages [35, 36].”
BackgroundArdi, V. C., Kupriyanova, T. A., Deryugina, E. I., & Quigley, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706438104 · Cited by 602 · cited 1×
“more easily activated [154] and freely available for the induction of angiogenesis [155].”
BackgroundMatrix metal loproteinases and the development of cancer
Coussens, L. M., & Werb, Z. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90178-7 · Cited by 568
The significance of hematogenous tumor cell clumps in the metastatic process.
Liotta, L. A., Saidel, M. G., & Kleinerman, J. I. (1976) · PubMed · Cited by 567
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564 · cited 2×
“In murine models of melanoma and fibrosarcoma, inhibition of IFN-β resulted in higher expression of genes associated with tumor promotion in TANs, such as vascular endothelial growth factor (VEGF) andMMP-9 [100].”
BackgroundNeutrophil-Derived Proteins: Selling Cytokines by the Pound
Cassatella, M. A. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60791-9 · Cited by 560
Gelatinase B functions as regulator and effector in leukocyte biology
Opdenakker, G., Van den Steen, P. E., Dubois, B., Nelissen, I., Van Coillie, E., Masure, S., Proost, P., & Van Damme, J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.851 · Cited by 553 · cited 1×
“more easily activated [154] and freely available for the induction of angiogenesis [155].”
BackgroundCho, H., Hur, H. W., Kim, S. W., Kim, S. H., Kim, J. H., Kim, Y. T., & Lee, K. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0516-3 · Cited by 529 · cited 1×
“Elevated serum neutrophil numbers, neutrophil factors, or a high neutrophil to lymphocyte ratio generally predict poor prognosis in most human cancers, including gastric [77–79], colon [80–82], lung [83], esophageal [84], pancreatic [85–87], cervical [88], and ovarian cancer [89, 90].”
BackgroundBronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N. P., & Zanovello, P. (2000) · Blood · doi:10.1182/blood.v96.12.3838 · Cited by 527 · cited 2×
“MDSCs are highly plastic and can become adherent F4/80, macrophage-like cells [30, 37], or, alternatively, differentiate into DCs when exposed to granulocyte-macrophage colony-stimulating factor (GMCSF) and IL-4 [18].”
BackgroundKuang, D.-M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., Yin, X.-Y., & Zheng, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.041 · Cited by 499 · cited 1×
“Hepatocellular carcinoma TANs correlate with increased risk of mortality [93]”
BackgroundShojaei, F., Wu, X., Qu, X., Kowanetz, M., Yu, L., Tan, M., Meng, Y. G., & Ferrara, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902280106 · Cited by 471 · cited 2×
“Combination treatments of anti-VEGF and anti-G-CSF or anti-Bv8 reduced CD11bGr-1 cell numbers, angiogenesis, and primary tumor growth [203].”
BackgroundChua, W., Charles, K. A., Baracos, V. E., & Clarke, S. J. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.100 · Cited by 468
Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., & von der Maase, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9498 · Cited by 461 · cited 1×
“Renal cell carcinoma TANs correlate with increased risk of mortality [92]”
BackgroundSTAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion
Kusmartsev, S., & Gabrilovich, D. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4880 · Cited by 445 · cited 1×
“MDSCs are highly plastic and can become adherent F4/80, macrophage-like cells [30, 37], or, alternatively, differentiate into DCs when exposed to granulocyte-macrophage colony-stimulating factor (GMCSF) and IL-4 [18].”
BackgroundNeutrophil Apoptosis: Relevance to the Innate Immune Response and Inflammatory Disease
Fox, S., Leitch, A. E., Duffin, R., Haslett, C., & Rossi, A. G. (2010) · Journal of Innate Immunity · doi:10.1159/000284367 · Cited by 441
Macrophages define the invasive microenvironment in breast cancer
Pollard, J. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107762 · Cited by 417 · cited 1×
“considered to be a major source of MMPs in tumors [136],”
BackgroundDe Larco, J. E., Wuertz, B. R. K., & Furcht, L. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0760 · Cited by 412 · cited 1×
“crete IL-8 have increased metastatic potential, proposed to be due in part to their ability to attract TANs [173].”
BackgroundBronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P., & Restifo, N. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5728 · Cited by 405 · cited 4×
“MDSCs are highly plastic and can become adherent F4/80, macrophage-like cells [30, 37], or, alternatively, differentiate into DCs when exposed to granulocyte-macrophage colony-stimulating factor (GMCSF) and IL-4 [18].”
BackgroundInfluentialInhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., & Strieter, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118734 · Cited by 403 · cited 1×
“metastasis, and angiogenesis in preclinical studies [195, 196] but still need to be tested in a clinical setting.”
Background(2010) · Advances in Cancer Research · doi:10.1016/s0065-230x(10)07003-x · Cited by 386
High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer
Shimada, H., Takiguchi, N., Kainuma, O., Soda, H., Ikeda, A., Cho, A., Miyazaki, A., Gunji, H., Yamamoto, H., & Nagata, M. (2010) · Gastric Cancer · doi:10.1007/s10120-010-0554-3 · Cited by 381
On the dual roles and polarized phenotypes of neutrophils in tumor development and progression
Piccard, H., Muschel, R. J., & Opdenakker, G. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.06.004 · Cited by 373 · cited 1×
“This concept has been termed the Bcountercurrent^ model [125, 126] (Fig.”
MethodYan, H. H., Pickup, M., Pang, Y., Gorska, A. E., Li, Z., Chytil, A., Geng, Y., Gray, J. W., Moses, H. L., & Yang, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0706 · Cited by 372 · cited 6×
“In tumor-bearing mice, increases in Gr-1CD11b cells have been reported in the lung [9], spleen [30], bone marrow [31], and circulation [9], and they have been shown to facilitate tumor growth [9].”
BackgroundInfluentialChemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice
Sawanobori, Y., Ueha, S., Kurachi, M., Shimaoka, T., Talmadge, J. E., Abe, J., Shono, Y., Kitabatake, M., Kakimi, K., Mukaida, N., et al. (2008) · Blood · doi:10.1182/blood-2008-01-136895 · Cited by 367 · cited 4×
“In murine tumors, three distinct cell populations have been found within the Gr-1CD11b MDSC population: SSC CD11bGr-1 / i n t eos inophi l - l ike cel l s , SSCCD11bGr-1 cells with neutrophil-like morphology, and SSCCD11bGr-1 macrophage-like cells that also express F4/80 and Ly6C [32].”
BackgroundInfluentialHuang, S., Mills, L., Mian, B., Tellez, C., McCarty, M., Yang, X.-D., Gudas, J. M., & Bar-Eli, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64164-8 · Cited by 361 · cited 1×
“metastasis, and angiogenesis in preclinical studies [195, 196] but still need to be tested in a clinical setting.”
BackgroundTumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Mishalian, I., Bayuh, R., Levy, L., Zolotarov, L., Michaeli, J., & Fridlender, Z. G. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1476-9 · Cited by 356 · cited 2×
“microenvironment to a pro-tumor phenotype [102].”
Huh, S. J., Liang, S., Sharma, A., Dong, C., & Robertson, G. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4442 · Cited by 352 · cited 6×
“cell injection, melanoma cell retention in the lung was increased threefold [143].”
BackgroundResultInfluentialYoun, J.-I., Kumar, V., Collazo, M., Nefedova, Y., Condamine, T., Cheng, P., Villagra, A., Antonia, S., McCaffrey, J. C., Fishman, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2526 · Cited by 350
A novel Ly6C/Ly6G‐based strategy to analyze the mouse splenic myeloid compartment
Rose, S., Misharin, A., & Perlman, H. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22012 · Cited by 347 · cited 2×
“between monocytes/macrophages and neutrophils, unlike Gr1 [36].”
BackgroundBhatti, I., Peacock, O., Lloyd, G., Larvin, M., & Hall, R. I. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.08.041 · Cited by 333
Leukocyte Elastase: Physiological Functions and Role in Acute Lung Injury
LEE, W. L., & DOWNEY, G. P. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2103040 · Cited by 326 · cited 9×
“Collectively , these data indicate that MMP-9-expressing TANs localize to the tumor periphery where they are actively involved in tumor cell escape into the vasculature via breakdown of the ECM (Fig.”
BackgroundInfluentialSharaiha, R. Z., Halazun, K. J., Mirza, F., Port, J. L., Lee, P. C., Neugut, A. I., Altorki, N. K., & Abrams, J. A. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1754-8 · Cited by 325 · cited 1×
“Elevated serum neutrophil numbers, neutrophil factors, or a high neutrophil to lymphocyte ratio generally predict poor prognosis in most human cancers, including gastric [77–79], colon [80–82], lung [83], esophageal [84], pancreatic [85–87], cervical [88], and ovarian cancer [89, 90].”
BackgroundNeutrophils roll on E-selectin.
Lawrence, M. B., & Springer, T. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6338 · Cited by 322
Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system.
Clark, R. A., & Klebanoff, S. J. (1975) · The Journal of experimental medicine · doi:10.1084/jem.141.6.1442 · Cited by 322 · cited 1×
“Early studies indicated that TANs are toxic to human tumor cells in vitro [60, 61] and in vivo [62–64].”
BackgroundNeutrophils: key mediators of tumour angiogenesis
Tazzyman, S., Lewis, C. E., & Murdoch, C. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00641.x · Cited by 318 · cited 1×
“Reducing TAN numbers in murine models of tumor angiogenesis has shown promising results, and a similar strategy could be effective in human disease [138, 194].”
BackgroundColombo, M. P., Ferrari, G., Stoppacciaro, A., Parenza, M., Rodolfo, M., Mavilio, F., & Parmiani, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.889 · Cited by 313 · cited 1×
“Only one study has shown that G-CSF expression at physiological levels leads to suppression of tumorigenicity in murine adenocarcinoma [68].”
BackgroundEvans, T. J., Buttery, L. D., Carpenter, A., Springall, D. R., Polak, J. M., & Cohen, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9553 · Cited by 312
Deryugina, E. I., Zajac, E., Juncker-Jensen, A., Kupriyanova, T. A., Welter, L., & Quigley, J. P. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.013 · Cited by 304 · cited 1×
“In a model of prostate cancer, the majority of MMP-9 expression was attributed to TANs [156].”
BackgroundBacterial infection induces nitric oxide synthase in human neutrophils.
Wheeler, M. A., Smith, S. D., García-Cardeña, G., Nathan, C. F., Weiss, R. M., & Sessa, W. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119121 · Cited by 298
Bekes, E. M., Schweighofer, B., Kupriyanova, T. A., Zajac, E., Ardi, V. C., Quigley, J. P., & Deryugina, E. I. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.031 · Cited by 298 · cited 1×
“associated with increased tumor cell intravasation [140].”
Jensen, T. O., Schmidt, H., Møller, H. J., Donskov, F., Høyer, M., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2012) · Cancer · doi:10.1002/cncr.26511 · Cited by 281 · cited 1×
“Melanoma Increased numbers of TANs indicated poor prognosis [95]”
BackgroundTrellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bankfalvi, A., Scherag, A., Hütte, J., Dominas, N., Lehnerdt, G. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25892 · Cited by 281 · cited 4×
“Head and neck squamous cell carcinoma (HNSCC) Increased TAN infiltration correlated with higher tumor stage and reduced survival [72]”
BackgroundInfluentialGhiringhelli, F., Ménard, C., Martin, F., & Zitvogel, L. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00445.x · Cited by 273
Vlodavsky, I., Ishai‐Michaeli, R., Bashkin, P., Levi, E., Korner, G., Bar‐Shavit, R., Fuks, Z., & Klagsbrun, M. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240450208 · Cited by 265 · cited 1×
“cancer progression by releasing sequestered growth factors [121], promoting angiogenesis, and allowing tumor cell”
BackgroundBroug-Holub, E., Toews, G. B., van Iwaarden, J. F., Strieter, R. M., Kunkel, S. L., Paine, R., & Standiford, T. J. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1139-1146.1997 · Cited by 263 · cited 1×
“in increased neutrophils during infection with Klebsiella pneumoniae [185].”
BackgroundJung, M. R., Park, Y. K., Jeong, O., Seon, J. W., Ryu, S. Y., Kim, D. Y., & Kim, Y. J. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21986 · Cited by 251
Scapini, P., Morini, M., Tecchio, C., Minghelli, S., Di Carlo, E., Tanghetti, E., Albini, A., Lowell, C., Berton, G., Noonan, D. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.5034 · Cited by 249
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
An, X., Ding, P.-R., Li, Y.-H., Wang, F.-H., Shi, Y.-X., Wang, Z.-Q., He, Y.-J., Xu, R.-H., & Jiang, W.-Q. (2010) · Biomarkers · doi:10.3109/1354750x.2010.491557 · Cited by 244
Wislez, M., Rabbe, N., Marchal-Sommé, J., Milleron, B. J., Crestani, B., Mayaud, C. M., Antoine, M., Soler, P., & Cadranel, J. L. (2003) · PubMed · Cited by 243
Filardy, A. A., Pires, D. R., Nunes, M. P., Takiya, C. M., Freire-de-Lima, C. G., Ribeiro-Gomes, F. L., & DosReis, G. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000017 · Cited by 238 · cited 1×
“For example, the phagocytic clearance of apoptotic neutrophils by macrophages stimulates an IL-10IL12 alternatively activated macrophage-like phenotype [184].”
BackgroundBellocq, A., Antoine, M., Flahault, A., Philippe, C., Crestani, B., Bernaudin, J., Mayaud, C. M., Milleron, B. J., Baud, L., & Cadranel, J. L. (1998) · PubMed Central · Cited by 228
The role of nitric oxide (NO·) in the carcinogenic process
Tamir, S., & Tannenbaum, S. R. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00021-2 · Cited by 221
Coffelt, S. B., Chen, Y.-Y., Muthana, M., Welford, A. F., Tal, A. O., Scholz, A., Plate, K. H., Reiss, Y., Murdoch, C., De Palma, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002802 · Cited by 220
Ding, P.-R., An, X., Zhang, R.-X., Fang, Y.-J., Li, L.-R., Chen, G., Wu, X.-J., Lu, Z.-H., Lin, J.-Z., Kong, L.-H., et al. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-010-1052-0 · Cited by 214
Neutrophil granules in health and disease
Häger, M., Cowland, J. B., & Borregaard, N. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02237.x · Cited by 209
Maus, U. A., Waelsch, K., Kuziel, W. A., Delbeck, T., Mack, M., Blackwell, T. S., Christman, J. W., Schlöndorff, D., Seeger, W., & Lohmeyer, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3273 · Cited by 202 · cited 1×
“recruitment, as it has been shown that macrophages can recruit neutrophils during lung inflammation, for example [120].”
BackgroundAcuff, H. B., Carter, K. J., Fingleton, B., Gorden, D. L., & Matrisian, L. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2502 · Cited by 200
IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer
Rotondo, R., Barisione, G., Mastracci, L., Grossi, F., Orengo, A. M., Costa, R., Truini, M., Fabbi, M., Ferrini, S., & Barbieri, O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24448 · Cited by 198
Hernandez‐Ilizaliturri, F. J., Jupudy, V., Ostberg, J. R., Oflazoglu, E., Huberman, A., Repasky, E. A., & Czuczman, M. S. (2003) · PubMed · Cited by 188
Neutrophils and respiratory tract DNA damage and mutagenesis: a review
Knaapen, A. M. (2006) · Mutagenesis · doi:10.1093/mutage/gel032 · Cited by 186
Pahler, J. C., Tazzyman, S., Erez, N., Chen, Y.-Y., Murdoch, C., Nozawa, H., Lewis, C. E., & Hanahan, D. (2008) · Neoplasia · doi:10.1593/neo.07871 · Cited by 184
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
Bieche, I., Chavey, C., Andrieu, C., Busson, M., Vacher, S., Le Corre, L., Guinebretiere, J.-M., Burlinchon, S., Lidereau, R., & Lazennec, G. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01301 · Cited by 183
Hermant, B., Bibert, S., Concord, E., Dublet, B., Weidenhaupt, M., Vernet, T., & Gulino-Debrac, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300351200 · Cited by 182 · cited 1×
“tach to and traverse the endothelium [13] and secrete proteolytic enzymes [14] to migrate through the basement membrane.”
BackgroundTazawa, H., Okada, F., Kobayashi, T., Tada, M., Mori, Y., Une, Y., Sendo, F., Kobayashi, M., & Hosokawa, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63580-8 · Cited by 178 · cited 2×
“shown to contribute to the metastatic process in a number of tumor models [9, 40, 69, 75, 143, 189, 211].”
BackgroundNielsen, B. S., Timshel, S., Kjeldsen, L., Sehested, M., Pyke, C., Borregaard, N., & Danø, K. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960103)65:1<57::aid-ijc10>3.0.co;2-f · Cited by 173
Refractoriness to Antivascular Endothelial Growth Factor Treatment: Role of Myeloid Cells
Shojaei, F., & Ferrara, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0925 · Cited by 171 · cited 1×
“It appears that a compensatory GCSF-mediated upregulation of the pro-angiogenic factor Bv8 in CD11bGr-1 cells contributes to this refractory response [205].”
BackgroundDifferential response of primary and metastatic melanomas to neutrophils attracted by IL‐8
Schaider, H., Oka, M., Bogenrieder, T., Nesbit, M., Satyamoorthy, K., Berking, C., Matsushima, K., & Herlyn, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10775 · Cited by 169 · cited 9×
“Melanoma cells transduced with IL-8 showed increased TAN infiltration with increasing concentrations of IL-8 [118].”
BackgroundInfluentialVerbeke, H., Karel, G., Damme, J. V., & Struyf, S. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.008 · Cited by 168 · cited 1×
“1 (CXCR1) and CXCR2 on the neutrophil cell surface [106, 107] (Fig.”
BackgroundThe paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances
Houghton, A. M. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11297 · Cited by 166 · cited 1×
“if this polarization does in fact represent a distinct neutrophil phenotype [101].”
BackgroundTomita, M., Shimizu, T. M., Ayabe, T., Yonei, A., & Onitsuka, T. (2011) · PubMed · Cited by 165
Welch, D. R., Schissel, D. J., Howrey, R. P., & Aeed, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5859 · Cited by 161 · cited 2×
“perimental lung metastasis of several rat adenocarcinomas [174].”
BackgroundSingh, S., Sadanandam, A., Nannuru, K. C., Varney, M. L., Mayer‐Ezell, R., Bond, R. W., & Singh, R. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2387 · Cited by 160
Bausch, D., Pausch, T. M., Krauß, T., Hopt, U. T., Fernández‐del‐Castillo, C., Warshaw, A. L., Thayer, S. P., & Keck, T. (2011) · Angiogenesis · doi:10.1007/s10456-011-9207-3 · Cited by 159 · cited 2×
“angiogenic factor in pancreatic ductal adenocarcinoma [139].”
BackgroundClinical Cancer Therapy by NK Cells via Antibody‐Dependent Cell‐Mediated Cytotoxicity
Alderson, K. L., & Sondel, P. M. (2011) · BioMed Research International · doi:10.1155/2011/379123 · Cited by 156
Recent developments and complexities in neutrophil transmigration
Woodfin, A., Voisin, M.-B., & Nourshargh, S. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283333930 · Cited by 153 · cited 1×
“Transmigration through the endothelial matrix/basement membrane, a process mediated by proteases [124].”
BackgroundPromoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase
Gong, L., Cumpian, A. M., Caetano, M. S., Ochoa, C. E., De la Garza, M. M., Lapid, D. J., Mirabolfathinejad, S. G., Dickey, B. F., Zhou, Q., & Moghaddam, S. J. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-154 · Cited by 150 · cited 1×
“[131], and inhibition of NE suppressed growth of gastric carcinoma cells [132] and lung tumors [133].”
BackgroundThe Yin-Yang of Tumor-Associated Neutrophils
Mantovani, A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.014 · Cited by 149 · cited 2×
“TANs appear to display a phenotypic spectrum similar to that of TAMs and hence can have both pro- and anti-tumor activities [97].”
BackgroundSmall molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases
Varney, M. L., Singh, S., Li, A., Mayer‐Ezell, R., Bond, R. W., & Singh, R. K. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.004 · Cited by 149 · cited 1×
“of human colon cancer cells to the liver, accompanied by reduced angiogenesis and increased apoptosis of malignant cells [198].”
BackgroundNing, Y., Labonte, M. J., Zhang, W., Bohanes, P. O., Gerger, A., Yang, D., Benhaim, L., Paez, D., Rosenberg, D. O., Nagulapalli Venkata, K. C., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0915 · Cited by 147 · cited 1×
“For example, in preclinical studies, the combination of a CXCR2 antagonist and chemotherapy reduced angiogenesis in xenografted tumors and reduced tumor growth [200].”
BackgroundSilva, M. T. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0910536 · Cited by 147 · cited 1×
“of apoptotic neutrophils [187] andmay even induce neutrophil”
BackgroundCrissman, J. D., Hatfield, J. S., Schaldenbrand, M. F., Sloane, B. F., & Honn, K. V. (1985) · PubMed · Cited by 142
BMP4 Inhibits Breast Cancer Metastasis by Blocking Myeloid-Derived Suppressor Cell Activity
Cao, Y., Slaney, C. Y., Bidwell, B. N., Parker, B. S., Johnstone, C. N., Rautela, J., Eckhardt, B. L., & Anderson, R. L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3171 · Cited by 138 · cited 2×
“ural killer (NK) cell activity [20–22], as well as suppression of anti-tumor T cell responses [23] and promotion of regulatory”
BackgroundGreen, A. R., Green, V. L., White, M. C., & Speirs, V. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970917)72:6<937::aid-ijc3>3.0.co;2-q · Cited by 137 · cited 1×
“It is expressed in a number of cancers including leukemia [113], breast cancer [114], cervical cancer [115], and melanoma [116].”
BackgroundOverexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer
Cheng, W.-P., Wang, C. S., Huang, Y., Tsai, M.-M., Liang, Y. J., & Lin, K. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq739 · Cited by 136
Human neutrophils facilitate tumor cell transendothelial migration
Wu, Q. D., Wang, J. H., Condron, C., Bouchier-Hayes, D., & Redmond, H. P. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c814 · Cited by 135 · cited 3×
“Conditioned medium from human breast tumor cells suppressed the cytocidal capacity of neutrophils [103], and HNSCC-conditioned medium inhibited neutrophil apoptosis and increased MMP-9 secretion [72].”
BackgroundRieber, N., Gille, C., Köstlin, N., Schäfer, I., Spring, B., Ost, M., Spieles, H., Kugel, H. A., Pfeiffer, M., Heininger, V, et al. (2013) · Clinical and Experimental Immunology · doi:10.1111/cei.12143 · Cited by 134
Interleukin‐8 modulates growth and invasiveness of estrogen receptor‐negative breast cancer cells
Yao, C., Lin, Y., Chua, M., Ye, C., Bi, J., Li, W., Zhu, Y., & Wang, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22930 · Cited by 132 · cited 1×
“lines, MDA-MB-231 and MDA-MB-468, reduced TAN infiltration [119].”
BackgroundIncreased IL-6 and IL-8 Levels in Cervicovaginal Secretions of Patients with Cervical Cancer
Tjiong, M. Y., van der Vange, N., ten Kate, F. J. W., Tjong‐A‐Hung, S. P., ter Schegget, J., Burger, M. P. M., & Out, T. A. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5358 · Cited by 132 · cited 1×
“It is expressed in a number of cancers including leukemia [113], breast cancer [114], cervical cancer [115], and melanoma [116].”
BackgroundCarr, K. D., Sieve, A. N., Indramohan, M., Break, T. J., Lee, S., & Berg, R. E. (2011) · European Journal of Immunology · doi:10.1002/eji.201041363 · Cited by 130 · cited 1×
“in experiments using Gr-1 antibodies need to be re-evaluated [44, 45].”
MethodShang, K., Bai, Y.-P., Wang, C., Wang, Z., Gu, H.-Y., Du, X., Zhou, X.-Y., Zheng, C.-L., Chi, Y.-Y., Mukaida, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051848 · Cited by 128
Nowicki, A., Szenajch, J., Ostrowska, G., Wojtowicz, A., Wojtowicz, K., Kruszewski, A. A., Maruszynski, M., Aukerman, S. L., & Wiktor-Jedrzejczak, W. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960103)65:1<112::aid-ijc19>3.0.co;2-i · Cited by 126
Swierczak, A., Cook, A. D., Lenzo, J. C., Restall, C. M., Doherty, J. P., Anderson, R. L., & Hamilton, J. A. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0190 · Cited by 126 · cited 5×
“recruitment to tumors and reducing the subsequent spontaneous metastasis to lung and bone [189].”
BackgroundInfluentialdi Celle, P., Carbone, A., Marchis, G. M. D., Zhou, D., Sozzani, S., Zupo, S., Pini, M., Mantovani, A., & Foà, R. (1994) · Blood · doi:10.1182/blood.v84.1.220.220 · Cited by 125
Scheibenbogen, C., hler, T. M., Häfele, J., HUNSTEIN, W., & Keilholz, U. (1995) · Melanoma Research · doi:10.1097/00008390-199506000-00006 · Cited by 125 · cited 1×
“It is expressed in a number of cancers including leukemia [113], breast cancer [114], cervical cancer [115], and melanoma [116].”
BackgroundPhan, V. T., Wu, X., Cheng, J. H., Sheng, R. X., Chung, A. S., Zhuang, G., Tran, C., Song, Q., Kowanetz, M., Sambrone, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303302110 · Cited by 116 · cited 2×
“Conversely, inhibition of neutrophil mobilization was able to increase the effectiveness of anti-VEGF therapy [204].”
BackgroundECK, M., SCHMAUßER, B., SCHELLER, K., BRÄNdlein, S., & MÜLLER-HERMELINK, H. K. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2003.02305.x · Cited by 113
Lenzo, J. C., Turner, A. L., Cook, A. D., Vlahos, R., Anderson, G. P., Reynolds, E. C., & Hamilton, J. A. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.58 · Cited by 107
Tazzyman, S., Barry, S. T., Ashton, S., Wood, P., Blakey, D., Lewis, C. E., & Murdoch, C. (2011) · International Journal of Cancer · doi:10.1002/ijc.25987 · Cited by 103 · cited 1×
“bers of TANs in lung tumor spheroids increased spheroid growth rates, and inhibition of TAN infiltration reduced spheroid growth [73].”
BackgroundMusiani, P., Allione, A., Modica, A., Lollini, P., Giovarelli, M., Cavallo, F., Belardelli, F., Forni, G., & Modesti, A. (1996) · PubMed · Cited by 101
Neutrophils in the Antitumoral Immune Response
Carlo, E. D., Forni, G., & Musiani, P. (2003) · KARGER eBooks · doi:10.1159/000071561 · Cited by 97
Neutrophils, Nitric Oxide Synthase, and Mutations in the Mutatect Murine Tumor Model
Sandhu, J. K., Privora, H., Wenckebach, G. F. C., & Birnboim, H. C. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64755-4 · Cited by 97 · cited 2×
“higher numbers of infiltrating TANs [163] and TAN numbers have been correlated with ROS activity and mutation frequency [117, 163].”
BackgroundNeutrophils influence melanoma adhesion and migration under flow conditions
Slattery, M. J., & Dong, C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11297 · Cited by 95
Souto, J. C., Vila, L., & Brú, A. (2011) · Medicinal Research Reviews · doi:10.1002/med.20185 · Cited by 90
Colombo, M. P., Lombardi, L., Stoppacciaro, A., Melani, C., Parenza, M., Bottazzi, B., & Parmiani, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.1.113 · Cited by 88 · cited 13×
“It is possible that patients with progressive disease may respond better to anti-G-CSFR therapies.”
BackgroundInfluentialHaqqani, A. S., Sandhu, J. K., & Birnboim, H. C. (2000) · Neoplasia · doi:10.1038/sj.neo.7900110 · Cited by 88 · cited 4×
“higher numbers of infiltrating TANs [163] and TAN numbers have been correlated with ROS activity and mutation frequency [117, 163].”
BackgroundInfluentialDong, C., Slattery, M. J., Liang, S., & Peng, H. (2005) · PubMed · Cited by 87
Strell, C., Lang, K., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.09.003 · Cited by 85 · cited 10×
“In these studies, CD11a (integrin αL), CD11b (integrin αM), and CD18 (integrin β2) were upregulated on neutrophils that had been exposed to tumor-conditioned medium and were shown to facilitate the transendothelial migration of breast tumor cells [103, 112] (Fig.”
BackgroundInfluential(1978) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(78)90317-3 · Cited by 85
Tumor Angiogenesis Induced by Granulocyte Chemotactic Protein-2 as a Countercurrent Principle
Coillie, E. V., Aelst, I. V., Wuyts, A., Vercauteren, R., Devos, R., Wolf‐Peeters, C. D., Damme, J. V., & Opdenakker, G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62527-8 · Cited by 83 · cited 1×
“can promote angiogenesis via the secretion of proangiogenic factors [146–148], and increased TAN infiltration has been associated with increased angiogenesis [149, 150].”
BackgroundAugier, S., Ciucci, T., Luci, C., Carle, G. F., Blin-Wakkach, C., & Wakkach, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902583 · Cited by 79 · cited 1×
“However, Gr-1 cells are not always considered to be MDSCs and are often described as neutrophils or macrophages [32, 33] or even monocytes [34].”
BackgroundOpdenakker, G., & Damme, J. V. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041796go · Cited by 77
Siders, W. M., Shields, J., Garron, C., Hu, Y., Boutin, P., Shankara, S., Weber, W., Roberts, B., & Kaplan, J. M. (2010) · Leukemia & Lymphoma · doi:10.3109/10428191003777963 · Cited by 77 · cited 1×
“pendent on antibody-dependent cell-mediated cytotoxicity (ADCC) mediated by neutrophils [207].”
BackgroundMentzel, T., Brown, L. F., Dvorak, H. F., Kuhnen, C., Stiller, K. J., Katenkamp, D., & Fletcher, C. D. �. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000327 · Cited by 75 · cited 1×
“Myxofibrosarcoma Increased numbers of TANs indicated poor prognosis [94]”
BackgroundWislez, M., Fleury‐Feith, J., Rabbe, N., Moreau, J., Cesari, D., Milleron, B. J., Mayaud, C. M., Antoine, M., Soler, P., & Cadranel, J. L. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62529-1 · Cited by 73 · cited 2×
“Lavage fluid supernatants from bronchioloalveolar adenocarcinoma patients significantly inhibited neutrophil apoptosis and prolonged their survival compared to lavage from healthy controls [104].”
BackgroundAliustaoğlu, M., Bilici, A. E., Şeker, M., Dane, F., Gocun, M., Konya, V., Ustaalıoğlu, B. B. Ö., & Gümüş, M. (2010) · PubMed · Cited by 72
Lichtenstein, A. K., & Kahle, J. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350119 · Cited by 72
Aeed, P. A., Nakajima, M., & Welch, D. R. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420521 · Cited by 72 · cited 5×
“intravasation into the vasculature [69, 122].”
BackgroundInfluentialHojilla, C. V., Wood, G. A., & Khokha, R. (2008) · Breast Cancer Research · doi:10.1186/bcr1980 · Cited by 72 · cited 1×
“It has long been known that MMPs can promote tumor progression [135], and while TAMs are”
BackgroundRole of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer.
Thavaramara, T., Phaloprakarn, C., Tangjitgamol, S., & Manusirivithaya, S. (2011) · PubMed · Cited by 71
Systemic Leukocyte Alterations Are Associated With Invasive Uterine Cervical Cancer
Tavares‐Murta, B. M., Mendonça, M. A. O., Duarte, N. L., da Silva, J. A., Mutão, T. S., Garcia, C. B., & Murta, E. F. C. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181ef8deb · Cited by 69 · cited 1×
“Elevated serum neutrophil numbers, neutrophil factors, or a high neutrophil to lymphocyte ratio generally predict poor prognosis in most human cancers, including gastric [77–79], colon [80–82], lung [83], esophageal [84], pancreatic [85–87], cervical [88], and ovarian cancer [89, 90].”
BackgroundExpression of α1‐6 fucosyltransferase in rat tissues and human cancer cell lines
Miyoshi, E., Uozumi, N., Noda, K., Hayashi, N., Hori, M., & Taniguchi, N. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970917)72:6<1117::aid-ijc29>3.0.co;2-# · Cited by 68
Suppression of anti-cancer immunity by regulatory T cells: Back to the future
Orentas, R. J., Kohler, M. E., & Johnson, B. D. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.11.007 · Cited by 66
Clavel, C., Polette, M., Doco‐Fenzy, M., Binninger, I., & Birembaut, P. L. (1992) · PubMed · Cited by 65
Evaluation of a series of bicyclic CXCR2 antagonists
Walters, I. A. S., Austin, C. A., Austin, R. P., Bonnert, R. V., Cage, P. A., Christie, M. I., Ebden, M. R., Gardiner, S. D., Grahames, C., Hill, S., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.039 · Cited by 63 · cited 1×
“target neutrophil-recruiting chemokine receptors are also being developed [197].”
BackgroundInfluence of migratory blood cells on the attachment of tumor cells to vascular endothelium
Starkey, J., Liggitt, H. D., Jones, W., & Hosick, H. L. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340417 · Cited by 63 · cited 1×
“Neutrophils can also increase tumor cell attachment to endothelial monolayers [142].”
BackgroundCytotoxic Effects of Peritoneal Neutrophils on a Syngeneic Rat Tumour
PICKAVER, A. H., Ratcliffe, N. A., WILLIAMS, A. E., & Smith, H. C. (1972) · Nature New Biology · doi:10.1038/newbio235186a0 · Cited by 62
Dvořàk, A. M., Connell, A. B., Proppe, K. H., & Dvorak, H. F. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.4.1240 · Cited by 58 · cited 2×
“In most cases, however, this cytotoxicity was elicited after neutrophils were primed with bacterial products or inflammatory agents [65] or after the immune system was primed and subsequently activated by injections of large numbers of the same tumor cells [6].”
BackgroundImmune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis
Thornton, L. M., Andersen, B. L., & Carson, W. E. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0485-6 · Cited by 58 · cited 1×
“rence when compared to patients with local recurrence [209].”
Yamashita, J., Ogawa, M., & Shirakusa, T. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.3.375 · Cited by 56 · cited 1×
“In breast cancer, increased tumor levels of the neutrophil-specific protease, NE, correlate with poor prognosis [91].”
BackgroundWada, Y., Yoshida, K., Hihara, J., Konishi, K., Tanabe, K., Ukon, K., Taomoto, J., Suzuki, T., & Mizuiri, H. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00278.x · Cited by 55 · cited 1×
“[131], and inhibition of NE suppressed growth of gastric carcinoma cells [132] and lung tumors [133].”
BackgroundMorikawa, K., Kamegaya, S., Yamazaki, M., & Mizuno, D. (1985) · PubMed · Cited by 54
Neutrophils and Angiogenesis: Potential Initiators of the Angiogenic Cascade
Benelli, R., Albini, A., & Noonan, D. M. (2003) · KARGER eBooks · doi:10.1159/000071560 · Cited by 53
Allenbach, C., Zufferey, C., Perez, C., Launois, P., Mueller, C., & Tacchini-Cottier, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6656 · Cited by 53
Roy, L. D., Ghosh, S., Pathangey, L. B., Tinder, T. L., Gruber, H. E., & Mukherjee, P. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-365 · Cited by 52 · cited 1×
“Inflammation at the primary tumor site [2] and at metastatic sites [169] increases the likelihood of successful metastasis [76, 170].”
BackgroundInflammation Joins the “Niche”
Peinado, H., Rafii, S., & Lyden, D. C. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.012 · Cited by 47
Nakamura, T., Kuwai, T., Kim, J.-S., Fan, D., Kim, S.-J., & Fidler, I. J. (2007) · Neoplasia · doi:10.1593/neo.07742 · Cited by 46 · cited 1×
“progression, including angiogenesis [141], as discussed below.”
Cited by
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334
“Neutrophils play important and contradictory roles in cancer development, as reflected by several recent reviews (Sionov et al., 2015; Swierczak et al., 2015; Uribe-Querol and Rosales, 2015; Coffelt et al., 2016; Mishalian et al., 2017).”
BackgroundTumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Masucci, M. T., Minopoli, M., & Carriero, M. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01146 · Cited by 649
“macrophages, TANs may acquire either an antitumor activity (N1 neutrophils), either a pro-tumor activity (N2 neutrophils) (3, 7, 8).”
BackgroundThe Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
Neutrophils in cancer: prognostic role and therapeutic strategies
Ocana, A., Nieto-Jiménez, C., Pandiella, A., & Templeton, A. J. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0707-7 · Cited by 459
“Neutrophil lifespan is altered in cancer and it is associated with maturation, extending from 7 h in normal conditions to 17 h in cancer [8, 9].”
BackgroundPrognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
Yang, R., Chang, Q., Meng, X., Gao, N., & Wang, W. (2018) · Journal of Cancer · doi:10.7150/jca.25691 · Cited by 441
Metadata
- Authors
- Swierczak, A., Mouchemore, K. A., Hamilton, J. A., & Anderson, R. L.
- Affiliations
- The Royal Melbourne Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- The University of Melbourne (AU)
- Corresponding author
- Anderson, Robin L.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2015-09-11
- Volume
- 34
- Issue
- 4
- Pages
- 735-751
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1722843651
- Cited by
- 220
- References
- 221
- Citations by year
- 2026: 5 · 2025: 23 · 2024: 21 · 2023: 31 · 2022: 29 · 2021: 28 · 2020: 32 · 2019: 17 · 2018: 17 · 2017: 11 · 2016: 5 · 2015: 1
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer and Metastasis Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Breast Cancer Foundation
- National Health and Medical Research Council
- National Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- neutrophils, tumor progression, metastasis, tumor growth, tumor microenvironment, tumor immunology
- MeSH terms
- Humans, Macrophages, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Neutrophils, Prognosis, T-Lymphocytes, Biomarkers, Tumor, Disease Progression, Neutrophil Infiltration, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.